Related references
Note: Only part of the references are listed.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Theranostic Advances in Breast Cancer in Nuclear Medicine
Nasim Vahidfar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Breast cancer
Nadia Harbeck et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Optimal imaging time for Tc-99m phytate lymphoscintigraphy for sentinel lymph node mapping in patients with breast cancer
Ching-Chun Ho et al.
TZU CHI MEDICAL JOURNAL (2019)
EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations
Jonathan I. Gear et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Internal dosimetry for radioembolization therapy with Yttrium-90 microspheres
Maryam Fallahpoor et al.
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS (2017)
68Ga-Ca-phytate particles: A potential lung perfusion agent of synthetic origin prepared in a cold kit format
William Hsieh et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2016)
Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes
K. Pohlodek et al.
NEOPLASMA (2016)
The role of general nuclear medicine in breast cancer
Lacey R. Greene et al.
JOURNAL OF MEDICAL RADIATION SCIENCES (2015)
Nuclear Imaging and Early Breast Cancer Detection
Laura Evangelista et al.
CURRENT RADIOPHARMACEUTICALS (2014)
Preoperative Axillary Ultrasound and Fine-needle Aspiration Biopsy in the Diagnosis of Axillary Metastases in Patients with Breast Cancer: Predictors of Accuracy and Future Implications
Jonathan Cools-Lartigue et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer
Francesco Giammarile et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Sentinel lymph node biopsy in breast cancer: review on various methodological approaches
Baha Zengel et al.
TUMORI (2013)
SPECT/CT scans allow precise anatomical location of sentinel lymph nodes in breast cancer and redefine lymphatic drainage from the breast to the axilla
R. F. Uren et al.
BREAST (2012)
Factors influencing the time of sentinel node visualization in breast cancer patients using intradermal injection of the radiotracer
Mohsen Aliakbarian et al.
AMERICAN JOURNAL OF SURGERY (2011)
99mTc-phytate is better than 99mTc-human serum albumin as a radioactive tracer for sentinel lymph node biopsy in breast cancer
H Takei et al.
SURGERY TODAY (2006)
Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer
A Fleissig et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using In-111-trastuzumab (Herceptin) Fab fragments
Y Tang et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
Chronic arm morbidity after curative breast cancer treatment: Prevalence and impact on quality of life
W Kwan et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Anti-human epidermal growth factor receptor 2 monoclonal antibody therapy for breast cancer
DS Leonard et al.
BRITISH JOURNAL OF SURGERY (2002)
The use of 99mTc-phytate for sentinel node mapping in melanoma, breast cancer and vulvar cancer:: a study of 100 cases
MGM Tavares et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2001)